XTANT MEDICAL HOLDINGS, INC.: 10-Q filed 2015-11-16

Name: XTANT MEDICAL HOLDINGS, INC.: 10-Q filed 2015-11-16
Creator: XTANT MEDICAL HOLDINGS, INC.

What XTANT MEDICAL HOLDINGS, INC. reported in its quarterly report filed 2015-11-16 (fiscal Q3 2015): 44 published measures, 115 facts as tagged in accession 0001144204-15-065520.

This filing

Form: 10-Q (quarterly report)
Filed: 2015-11-16
Fiscal period: fiscal Q3 2015
Accession: 0001144204-15-065520 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All XTANT MEDICAL HOLDINGS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2015-09-30	126,226,693	USD
At 2014-12-31	27,950,891	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2015-09-30	129,057,714	USD
At 2014-12-31	35,725,806	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2015-09-30	-2,831,021	USD
At 2014-12-31	-7,774,915	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2015-09-30	7,970,433	USD
At 2014-12-31	4,468,208	USD
At 2014-09-30	6,953,279	USD
At 2013-12-31	3,046,340	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-6,688,974	USD	92
2015-01-01 to 2015-09-30	-13,761,754	USD	273
2014-07-01 to 2014-09-30	-1,165,783	USD	92
2014-01-01 to 2014-09-30	-7,205,572	USD	273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	-9,027,080	USD	273
2014-01-01 to 2014-09-30	-5,169,527	USD	273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	85,846,261	USD	273
2014-01-01 to 2014-09-30	9,256,918	USD	273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	-73,374,774	USD	273
2014-01-01 to 2014-09-30	-180,452	USD	273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2015-09-30	-84,629,192	USD
At 2014-12-31	-70,866,542	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	10,432,622	shares	92
2015-01-01 to 2015-09-30	8,100,226	shares	273
2014-07-01 to 2014-09-30	6,233,751	shares	92
2014-01-01 to 2014-09-30	5,711,452	shares	273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	10,432,622	shares	92
2015-01-01 to 2015-09-30	8,100,226	shares	273
2014-07-01 to 2014-09-30	6,233,751	shares	92
2014-01-01 to 2014-09-30	5,711,452	shares	273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-0.64	USD/shares	92
2015-01-01 to 2015-09-30	-1.7	USD/shares	273
2014-07-01 to 2014-09-30	-0.19	USD/shares	92
2014-01-01 to 2014-09-30	-1.26	USD/shares	273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-0.64	USD/shares	92
2015-01-01 to 2015-09-30	-1.7	USD/shares	273
2014-07-01 to 2014-09-30	-0.19	USD/shares	92
2014-01-01 to 2014-09-30	-1.26	USD/shares	273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2015-09-30	11,433,064	USD
At 2014-12-31	4,654,527	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	881,681	USD	273
2014-01-01 to 2014-09-30	938,785	USD	273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-4,884,693	USD	92
2015-01-01 to 2015-09-30	-8,000,653	USD	273
2014-07-01 to 2014-09-30	-1,250,356	USD	92
2014-01-01 to 2014-09-30	-3,774,364	USD	273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2015-09-30	44,370,953	USD
At 2014-12-31	19,108,077	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	2,111,721	USD	92
2015-01-01 to 2015-09-30	4,930,941	USD	273
2014-07-01 to 2014-09-30	1,498,508	USD	92
2014-01-01 to 2014-09-30	4,216,109	USD	273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2015-09-30	16,737,278	USD
At 2014-12-31	8,482,452	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2015-09-30	7,485,220	USD
At 2014-12-31	3,876,760	USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

Period	Value	Unit	Days
At 2015-09-30	23,997,218	USD
At 2014-12-31	0	USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

Period	Value	Unit	Days
At 2015-09-30	42,223,856	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2015-09-30	13,318,450	USD
At 2014-12-31	4,427,081	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	16,542,040	USD	92
2015-01-01 to 2015-09-30	32,205,963	USD	273
2014-07-01 to 2014-09-30	6,686,126	USD	92
2014-01-01 to 2014-09-30	20,305,819	USD	273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2015-09-30	22,042,508	USD
At 2014-12-31	9,558,648	USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	11,657,347	USD	92
2015-01-01 to 2015-09-30	24,205,310	USD	273
2014-07-01 to 2014-09-30	5,435,770	USD	92
2014-01-01 to 2014-09-30	16,531,455	USD	273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	794,464	USD	92
2015-01-01 to 2015-09-30	1,519,196	USD	273
2014-07-01 to 2014-09-30	378,252	USD	92
2014-01-01 to 2014-09-30	955,111	USD	273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2015-09-30	11,886,107	shares
At 2014-12-31	6,679,646	shares

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2015-09-30	17,125,732	USD
At 2014-12-31	9,527,785	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2015-09-30	5,692,668	USD
At 2014-12-31	4,873,258	USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

Period	Value	Unit	Days
At 2015-09-30	42,223,856	USD
At 2014-12-31	655,490	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2015-09-30	2,520,464	USD
At 2014-12-31	1,598,539	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2015-09-30	6,716,897	USD
At 2014-12-31	1,921,301	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2015-09-30	1,039,562	USD
At 2014-12-31	654,140	USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	3,980,805	USD	92
2015-01-01 to 2015-09-30	8,805,104	USD	273
2014-07-01 to 2014-09-30	2,282,386	USD	92
2014-01-01 to 2014-09-30	6,664,982	USD	273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	563,790	USD	273
2014-01-01 to 2014-09-30	440,397	USD	273

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	2,403,934	USD	273
2014-01-01 to 2014-09-30	498,343	USD	273

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	1,423,983	USD	273
2014-01-01 to 2014-12-31	77,022	USD	365

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-89,926	USD	92
2015-01-01 to 2015-09-30	-193,052	USD	273
2014-07-01 to 2014-09-30	-70,344	USD	92
2014-01-01 to 2014-09-30	-253,289	USD	273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-1,804,281	USD	92
2015-01-01 to 2015-09-30	-5,761,101	USD	273
2014-07-01 to 2014-09-30	84,573	USD	92
2014-01-01 to 2014-09-30	-3,431,208	USD	273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	2,118,483	USD	273
2014-01-01 to 2014-09-30	5,876,299	USD	273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	2,801,124	USD	273
2014-01-01 to 2014-09-30	-346,151	USD	273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	-477,818	USD	273
2014-01-01 to 2014-09-30	350,198	USD	273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	694,326	USD	273
2014-01-01 to 2014-09-30	884,436	USD	273

Inspect the source

Entity: XTANT MEDICAL HOLDINGS, INC. / CIK 0001453593
Captured: 2026-09-20T09:05:45.017Z
SEC response SHA-256: f9d053dab2b3ef777d55d83bfe931eecec3ce57ca397c87dd6d1e27ae911a14c

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001453593.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))